Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Cash from Investing Activities (2016 - 2025)

Lifecore Biomedical, Inc. \De\ has reported Cash from Investing Activities over the past 16 years, most recently at -$2.1 million for Q2 2025.

  • For Q2 2025, Cash from Investing Activities rose 22.71% year-over-year to -$2.1 million; the TTM value through May 2025 reached -$6.4 million, up 65.13%, while the annual FY2025 figure was -$6.4 million, 65.13% up from the prior year.
  • Cash from Investing Activities for Q2 2025 was -$2.1 million at Lifecore Biomedical, Inc. \De\, down from $1.5 million in the prior quarter.
  • Over five years, Cash from Investing Activities peaked at $65.2 million in Q1 2022 and troughed at -$17.5 million in Q2 2022.
  • A 5-year average of $2.1 million and a median of -$3.1 million in 2024 define the central range for Cash from Investing Activities.
  • Biggest five-year swings in Cash from Investing Activities: soared 139607.41% in 2021 and later crashed 2136.28% in 2023.
  • Year by year, Cash from Investing Activities stood at -$5.4 million in 2021, then increased by 29.06% to -$3.8 million in 2022, then fell by 10.73% to -$4.3 million in 2023, then surged by 42.74% to -$2.4 million in 2024, then increased by 14.06% to -$2.1 million in 2025.
  • Business Quant data shows Cash from Investing Activities for LFCR at -$2.1 million in Q2 2025, $1.5 million in Q1 2025, and -$2.4 million in Q4 2024.